Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid improvement in symptoms for patients suffering for decades from the neurological ...

Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...

Actor Abhay Deol has revealed undergoing stem cell therapy in South Korea to treat chronic knee pain and sciatica caused by a ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Stem cell therapy uses stem cells or their derivatives to repair and regenerate tissues that have been diseased, damaged, or ...

Early phase 1 data suggest that in vivo, off-the-shelf CAR T therapy may be feasible in multiple myeloma, offering the ...